Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

The marine sponge metabolite hymenialdisine is a potent inhibitor of a variety of kinases including MEK-1, GSK-3 beta, and CK1. In addition, hymenialdisine and debromohymenialdisine exhibit inhibition of the G(2) cell cycle checkpoint at micromolar concentrations. We report herein the potent inhibition of cell cycle kinase Chk2 by the indolic-hymenialdisine indoloazepine 1 (IC(50)=8 nM).

Knowledge Graph

Similar Paper

Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors
Bioorganic & Medicinal Chemistry 2012.0
Inhibition of Cytokine Production by Hymenialdisine Derivatives
Journal of Medicinal Chemistry 2004.0
Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine
European Journal of Medicinal Chemistry 2012.0
Aldisine Alkaloids from the Philippine Sponge <i>Stylissa </i><i>m</i><i>assa</i> Are Potent Inhibitors of Mitogen-Activated Protein Kinase Kinase-1 (MEK-1)
Journal of Medicinal Chemistry 2002.0
Aldisine Alkaloids from the Philippine Sponge <i>Stylissa </i><i>m</i><i>assa</i> Are Potent Inhibitors of Mitogen-Activated Protein Kinase Kinase-1 (MEK-1)
Journal of Medicinal Chemistry 2002.0
1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase:  Synthesis, Preliminary SAR, and Biological Activities
Journal of Medicinal Chemistry 2005.0
Fused-azepinones: Emerging scaffolds of medicinal importance
European Journal of Medicinal Chemistry 2021.0
Design, Synthesis, and Biological Activity of 5,10-Dihydro-dibenzo[b,e][1,4]diazepin-11-one-Based Potent and Selective Chk-1 Inhibitors
Journal of Medicinal Chemistry 2007.0